Skip to content

Palliative Care in Spinal Muscular Atrophy (SMA) 1

Evaluation of Palliative and Supportive Care for Spinal Muscular Atrophy (SMA) Type 1 Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01862042
Acronym
ASI1
Enrollment
39
Registered
2013-05-24
Start date
2012-06-30
Completion date
2018-06-11
Last updated
2025-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Muscular Atrophy 1

Keywords

Spinal Muscular Atrophy (SMA) type 1, Supportive care, Palliative care

Brief summary

The purpose of this study is to evaluate the quality of supportive and palliative care for SMA type 1 patients.

Detailed description

Spinal Muscular Atrophy Type I (SMA I) is the most severe form of SMA. It presents in infancy and death occurs by 2 years. There is actually no curative treatment for this pathology. Support and help must be provided from the time of presentation till death and usually this period is quite short, about a couple of months. Variations in medical practice have be seen, depending on the medical experience and sometimes coupled with differences in family resources and values. The aim of the study is to evaluate the needs of the patients and their families, the medical practices, and to describe a cohort of SMA type 1 patients with the natural history of this disease. For this, a follow-up diary will be done, and this diary will be completed by the families and the different practitioners working with the patient. Will be noted in it : physical signs, all therapeutic choices and actions, evaluation of the pain and treatments. A special part of this follow-up diary will be completed by the medical doctors, after the death of the patient, with all the medication used at time of death and the conditions of the death. One year after the death of the patient, a questionnaire will be proposed to the parents of the child by a psychologist. This questionnaire will estimate the benefice of the follow-up diary, and the improvements to give in the diagnostic strategies, recommendations for assessment and monitoring, and therapeutic interventions in SMA type 1.

Interventions

OTHERFollow-up diary and questionnaire

A follow-up diary will be completed by the families and the different practitioners working with the patient. One year after the death of the patient, a questionnaire will be proposed to the parents of the child by a psychologist.

Sponsors

URC-CIC Paris Descartes Necker Cochin
CollaboratorOTHER
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Days to 1 Years
Healthy volunteers
No

Inclusion criteria

* SMA type 1 under 1 an * Genetic confirmation

Exclusion criteria

* No genetic confirmation * SMA type 1 over 1 year

Design outcomes

Primary

MeasureTime frameDescription
%O2until 2 yearsQuantitative evaluation of care : oxygen therapy and Invasive ventilation

Secondary

MeasureTime frameDescription
Qualitative evaluation of the practices of careuntil 2 yearsAnalysis of the semi-structured questionnaire completed remotely by the methods of analysis semi-qualitative. Identification of the principal challenges faced by parents and satisfaction criteria or non-face to the proposed solutions.
Evaluation of nutritional statusuntil 2 yearsQuantitative evaluation of care : nutritional status and enteral nutrition
Evaluation of orthopedic facilitiesuntil 2 yearsQuantitative evaluation of care : kinesitherapy and orthopedic facility
Evaluation of comfortuntil 2 yearsquantitative evaluation of care : criterion for pain analgesics and sedatives care

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026